February 27, 2026 · Form 4 insider transaction
ROMANO KATHRYN bought 5,442 shares of Krystal Biotech, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Each RSU represents a contingent right to receive one share of the Company's common stock, subject to the Reporting Person's continued service to the Company on each applicable vesting date.; The number of RSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming the Reporting Person's continued service to the Company on all applicable vesting dates.; The RSUs vest in four equal annual installments with the first installment vesting on February 27, 2027.